Long term complications in patients implanted with subcutaneous implantable defibrillators Real-world data from the Extended ELISIR experience.

[1]  James E. Ip.  Premature battery depletion of EMBLEM subcutaneous implantable cardioverter‐defibrillators , 2021, Journal of cardiovascular electrophysiology.

[2]  M. Casula,et al.  Subcutaneous versus Transvenous Implantable Defibrillator: an updated Meta-analysis. , 2020, Heart rhythm.

[3]  K. Gutleben,et al.  Fracture of an S‐ICD lead after two prior transvenous lead‐related complications with conventional defibrillators , 2020, Pacing and clinical electrophysiology : PACE.

[4]  A. Curnis,et al.  Neglected lead tip erosion: An unusual case of S‐ICD inappropriate shock , 2020, Journal of cardiovascular electrophysiology.

[5]  P. Lambiase,et al.  Subcutaneous or Transvenous Defibrillator Therapy , 2020, New England Journal of Medicine.

[6]  C. Leclercq,et al.  Subcutaneous Implantable Cardioverter-Defibrillator Lead Extraction: First Multicenter French Experience. , 2020, JACC. Clinical electrophysiology.

[7]  M. Gold,et al.  Outcomes of Subcutaneous Implantable Cardioverter Defibrillator in Dialysis Patients: Results from the S-ICD-Post Approval Study. , 2020, Heart rhythm.

[8]  Emily P. Zeitler,et al.  Defibrillator Lead Survival: Where Is the Threshold? , 2020, Circulation. Cardiovascular quality and outcomes.

[9]  M. Biffi,et al.  Real-life outcome of implantable cardioverter-defibrillator and cardiac resynchronization defibrillator replacement/upgrade in a contemporary population: observations from the multicentre DECODE registry. , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[10]  A. Wilde,et al.  A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: The PRAETORIAN score. , 2019, Heart rhythm.

[11]  D. Callans,et al.  Impact of Body Mass Index on Safety and Efficacy of the Subcutaneous Implantable Cardioverter-Defibrillator. , 2018, JACC. Clinical electrophysiology.

[12]  Michael P. Brunner,et al.  Transvenous Lead Extraction in Chronic Kidney Disease and Dialysis Patients With Infected Cardiac Devices , 2018, Circulation. Arrhythmia and electrophysiology.

[13]  J. DiNicolantonio,et al.  Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies. , 2017, JACC. Clinical electrophysiology.

[14]  J. Healey,et al.  Clinically Significant Pocket Hematoma Increases Long-Term Risk of Device Infection: BRUISE CONTROL INFECTION Study. , 2016, Journal of the American College of Cardiology.

[15]  Pier D. Lambiase,et al.  The learning curve associated with the introduction of the subcutaneous implantable defibrillator , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[16]  Laura A. Hatfield,et al.  Transvenous Implantable Cardioverter‐Defibrillator (ICD) Lead Performance: A Meta‐Analysis of Observational Studies , 2015, Journal of the American Heart Association.

[17]  A. Auricchio,et al.  Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results. , 2015, Heart rhythm.

[18]  Pier D. Lambiase,et al.  Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry. , 2015, Journal of the American College of Cardiology.

[19]  Michael P. Brunner,et al.  Clinical predictors of adverse patient outcomes in an experience of more than 5000 chronic endovascular pacemaker and defibrillator lead extractions. , 2014, Heart rhythm.

[20]  Ellen Aagaard Nohr,et al.  Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark , 2013, European heart journal.

[21]  A. Go,et al.  Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. , 2013, JAMA.

[22]  R. Hauser,et al.  Riata implantable cardioverter-defibrillator lead failure: analysis of explanted leads with a unique insulation defect. , 2012, Heart rhythm.

[23]  H. Halperin,et al.  End‐Stage Renal Disease Predicts Complications in Pacemaker and ICD Implants , 2011, Journal of cardiovascular electrophysiology.

[24]  D. Hayes,et al.  Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure. , 2009, Heart rhythm.